Spinocerebellar Ataxia Type 29Symptoms, Doctors, Treatments, Advances & More
Spinocerebellar Ataxia Type 29 Overview
Learn About Spinocerebellar Ataxia Type 29
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Kym Boycott practices practicing medicine in Ottawa, Canada. Ms. Boycott is rated as a Distinguished expert by MediFind in the treatment of Spinocerebellar Ataxia Type 29. She is also highly rated in 60 other conditions, according to our data. Her clinical expertise encompasses Mckusick-Kaufman Syndrome, Floating-Harbor Syndrome, Achalasia Microcephaly Syndrome, Microcephaly, and Gastrostomy.
Sally Lynch practices practicing medicine in Dublin, Ireland. Ms. Lynch is rated as a Distinguished expert by MediFind in the treatment of Spinocerebellar Ataxia Type 29. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses KBG Syndrome, Spinocerebellar Ataxia Type 29, Micrognathia, and X-Linked Infantile Spinal Muscular Atrophy.
Katsuhiko Mikoshiba practices practicing medicine in Shanghai, China. Mikoshiba is rated as a Distinguished expert by MediFind in the treatment of Spinocerebellar Ataxia Type 29. They are also highly rated in 4 other conditions, according to our data. Their clinical expertise encompasses Spinocerebellar Ataxia Type 29, Spinocerebellar Ataxia Type 15, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Primary Lateral Sclerosis.
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...